Parallel Advisors, LLC Virpax Pharmaceuticals, Inc. Transaction History
Parallel Advisors, LLC
- $3.87 Billion
- Q2 2024
A detailed history of Parallel Advisors, LLC transactions in Virpax Pharmaceuticals, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 1 shares of VRPX stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1
Previous 1
-0.0%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VRPX
# of Institutions
1Shares Held
1Call Options Held
0Put Options Held
0About Virpax Pharmaceuticals, Inc.
- Ticker VRPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,714,600
- Market Cap $7.61M
- Description
- Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical no...